Cargando…
Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?
Autores principales: | Semsarian, Caitlin R., Ma, Tara, Nickel, Brooke, Scolyer, Richard A., Ferguson, Peter M., Soyer, H. Peter, Parker, Lisa, Barratt, Alexandra, Thompson, John F., Bell, Katy J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546461/ https://www.ncbi.nlm.nih.gov/pubmed/35007335 http://dx.doi.org/10.1111/bjd.21010 |
Ejemplares similares
-
Should low-risk DCIS lose the cancer label? An evidence review
por: Ma, Tara, et al.
Publicado: (2023) -
Genome-Wide Analysis of Gene and Protein Expression of Dysplastic Naevus Cells
por: Gao, Linda, et al.
Publicado: (2012) -
Incidence of cutaneous melanoma in patients with histologically confirmed dysplastic naevus: A follow‐up study in a large UK Healthcare Trust
por: McDonald, L., et al.
Publicado: (2021) -
Nævus
por: Duncan, John
Publicado: (1886) -
Nævus
Publicado: (1848)